Loreto Martínez-González (Loreto Martinez-Gonzalez)

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 10

Top Topics

Tyrosine Kinase

Amyotrophic Lateral Sclerosis

Top Venues

Journal of enzyme inhibition and medicinal chemistry

Expert opinion on investigational drugs

International journal of molecular sciences

This page only lists publications with an associated author ORCID identifier.

Publications

Elisa Rojas-Prats, Loreto Martínez-González, Carmen Gil, David Ramírez, Ana Martinez
Druggable cavities and allosteric modulators of the cell division cycle 7 (CDC7) kinase. Journal of enzyme inhibition and medicinal chemistry 39 (1) (2024)
Elisa Rojas-Prats, Loreto Martínez-González, Carmen Gil, David Ramírez, Ana Martinez
Druggable cavities and allosteric modulators of the cell division cycle 7 (CDC7) kinase. Journal of enzyme inhibition and medicinal chemistry 39 (1) (2024)
Elisa Rojas-Prats, Loreto Martínez-González, Carmen Gil, David Ramírez, Ana Martinez
Druggable cavities and allosteric modulators of the cell division cycle 7 (CDC7) kinase. Journal of enzyme inhibition and medicinal chemistry 39 (1) (2024)
Elisa Rojas-Prats, Loreto Martínez-González, Carmen Gil, David Ramírez, Ana Martinez
Druggable cavities and allosteric modulators of the cell division cycle 7 (CDC7) kinase. Journal of enzyme inhibition and medicinal chemistry 39 (1) (2024)
Loreto Martínez-González, Ana Martinez
Emerging clinical investigational drugs for the treatment of amyotrophic lateral sclerosis. Expert opinion on investigational drugs 32 (2) (2023)
Loreto Martínez-González, Ana Martinez
Emerging clinical investigational drugs for the treatment of amyotrophic lateral sclerosis. Expert opinion on investigational drugs 32 (2) (2023)
Loreto Martínez-González, Ana Martinez
Emerging clinical investigational drugs for the treatment of amyotrophic lateral sclerosis. Expert opinion on investigational drugs 32 (2) (2023)
Loreto Martínez-González, Ana Martinez
Emerging clinical investigational drugs for the treatment of amyotrophic lateral sclerosis. Expert opinion on investigational drugs (2023)
Loreto Martínez-González, Claudia Gonzalo-Consuegra, Marta Gómez-Almería, Gracia Porras, Eva de Lago, Ángeles Martín-Requero, Ana Martinez
Tideglusib, a Non-ATP Competitive Inhibitor of GSK-3β as a Drug Candidate for the Treatment of Amyotrophic Lateral Sclerosis. International journal of molecular sciences 22 (16) (2021)
Elisa Rojas-Prats, Carlota Tosat-Bitrián, Loreto Martínez-González, Vanesa Nozal, Daniel I Pérez, Ana Martinez
Increasing Brain Permeability of PHA-767491, a Cell Division Cycle 7 Kinase Inhibitor, with Biodegradable Polymeric Nanoparticles. Pharmaceutics 13 (2) (2021)